Stock Research: UCB

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

UCB

ENXTBR:UCB BE0003739530
72
  • Value
    20
  • Growth
    97
  • Safety
    Safety
    31
  • Combined
    49
  • Sentiment
    94
  • 360° View
    360° View
    72
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

UCB SA is a biopharmaceutical and specialty chemical company specializing in central nervous system (CNS) and immunology diseases. Its main business includes CNS disorders like epilepsy and immunology disorders such as rheumatoid arthritis. UCB SA operates globally, with a focus on Europe and North America. In the last fiscal year, the company had a market cap of $39,605 million, profits of $4,555 million, revenue of $6,369 million, and 9378 employees.

more
Index
BEL20
Human Rights
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 6 79 74
Growth
97 90 89 19
Safety
Safety
31 24 24 38
Sentiment
94 61 10 38
360° View
360° View
72 37 45 30
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
54 49 36 49
Opinions Change
56 59 24 48
Pro Holdings
n/a 45 14 56
Market Pulse
83 69 47 27
Sentiment
94 61 10 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
20 6 79 74
Growth
97 90 89 19
Safety Safety
31 24 24 38
Combined
49 24 82 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
17 11 46 54
Price vs. Earnings (P/E)
25 15 54 71
Price vs. Book (P/B)
28 21 81 78
Dividend Yield
32 32 70 65
Value
20 6 79 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
82 94 54 6
Profit Growth
94 54 77 48
Capital Growth
90 56 76 21
Stock Returns
67 96 52 54
Growth
97 90 89 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
60 61 48 43
Refinancing
19 18 23 24
Liquidity
25 31 40 56
Safety Safety
31 24 24 38

Similar Stocks

Discover high‑ranked alternatives to UCB and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: